Skip to content
International Academy for Clinical Hematology (IACH) Logo
  • About
    • Bylaws
    • Membership
    • Founders
    • Mission
    • Topics
    • Journal
    • IACH Supporters
    • Contact
  • Meetings
    • Controversies in Multiple Myeloma (COMy)
    • Controversies in MDS and AML (COMydAL)
    • Controversies in Lymphoma (COLYM)
    • MPNControversies & Debates (MPN Co&D)
    • Annual Meeting of the IACH
    • Summit on Immunotherapy and Cellular Therapy in Cancer (ICTC)
  • Webinars
  • Post-Cong. webinars
  • Special webinars
  • Shoulders of Giants
  • Journal Club
  • IACH News

Christopher Hourigan – How to distinguish to Acute Myeloid Leukemia from Non-Malignant Clonal Hematopoiesis?

Home/All/Christopher Hourigan – How to distinguish to Acute Myeloid Leukemia from Non-Malignant Clonal Hematopoiesis?
Previous Next

Christopher Hourigan – How to distinguish to Acute Myeloid Leukemia from Non-Malignant Clonal Hematopoiesis?

By Amnon Ron|2021-09-09T14:49:42+00:00September 9th, 2021|All|Comments Off on Christopher Hourigan – How to distinguish to Acute Myeloid Leukemia from Non-Malignant Clonal Hematopoiesis?

Share This Story, Choose Your Platform!

FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkEmail

About the Author: Amnon Ron

Related Posts

  • Prof. He Huang – Non-viral, specifically targeted CAR-T cells, achieve high safety and efficacy in B-NHL

    Prof. He Huang – Non-viral, specifically targeted CAR-T cells, achieve high safety and efficacy in B-NHL

  • Prof. Mikkael Sekeres – Azacitidine plus venetoclax for myelodysplastic syndromes

    Prof. Mikkael Sekeres – Azacitidine plus venetoclax for myelodysplastic syndromes

  • Dr. Adi Nagler – Single cell sequencing to chronic lymphocytic leukemia

    Dr. Adi Nagler – Single cell sequencing to chronic lymphocytic leukemia

  • Prof. Meral Beksac – The recent developments in the field of bispecific T-cell engagers

    Prof. Meral Beksac – The recent developments in the field of bispecific T-cell engagers

  • Prof. Selim Corbacioglu – The importance of veno-occlusive disease prophylaxis

    Prof. Selim Corbacioglu – The importance of veno-occlusive disease prophylaxis

About

The IACH is founded by an international group of physicians whose focus is to promote good clinical practice in the field of clinical hematology.

Contact

info@clinical-hematology.org
+44 203 291 1603
Copyright © 2022 International Academy for Clinical Hematology | All Rights Reserved
Page load link
Go to Top